Search Within

Semanti Mukherjee

  1. "David Jones"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Alumni (GSK) (6)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  3. Clinical Genetics Service (6)
  4. Department of Medicine (6)
  5. Department of Pathology and Laboratory Medicine (6)
  6. GSK Faculty (6)

More Groups

People
  1. David Jones (6)
  2. Kenneth Offit (6)
  3. Chaitanya Bandlamudi (5)
  4. Michael Berger (5)
  5. Zsofia Stadler (5)
  6. Charles Rudin (4)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2019 (1)
  4. 2018 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Epidemiology Biomarkers and Prevention (1)
  3. Cancer Research (1)
  4. Science Translational Medicine (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. American Association for the Advancement of Science (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition
    Meeting Abstract

    Walsh, M. F.; Mukherjee, S.; Gao, M.; Fiala, E.; Mauguen, A.; Kemel, Y.; Bandlamudi, C.; Mehine, M.; Carlo, M. I.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos
    Journal Article

    Liu, Y.; Chudgar, N.; Mastrogiacomo, B.; He, D.; Lankadasari, M. B.; Bapat, S.; Jones, G. D.; Sanchez-Vega, F.; Tan, K. S.; Schultz, N.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Inherited truncating RAD52 variant discovered using integrated germline-somatic analysis predicts clinical outcome in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Srinivasan, P.; Bandlamudi, C.; Hellmann, M. D.; Ravichandran, V.; Selvan, M. E.; Kemel, Y.; Mandelker, D.; Zauderer, M.; Walsh, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Frequency of actionable cancer predisposing germline mutations in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save